Risk factors for low adherence to methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder
Abstract Poor adherence is a major concern in the treatment of attention-deficit/hyperactivity disorder (ADHD). The objective of this study was to evaluate factors linked to early interruption of and low adherence to treatment with osmotic-release oral system methylphenidate hydrochloride (OROS-MPH)...
Guardado en:
Autores principales: | Asami Ishizuya, Minori Enomoto, Hisateru Tachimori, Hidehiko Takahashi, Genichi Sugihara, Shingo Kitamura, Kazuo Mishima |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7049cd516c5a4bc6a30535f2b68cddc3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
por: Valdizán-Usón JR, et al.
Publicado: (2013) -
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Rajasree Nair, et al.
Publicado: (2009) -
Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
por: Masi G, et al.
Publicado: (2019) -
Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou WJ, et al.
Publicado: (2018) -
Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
por: Jan K Buitelaar, et al.
Publicado: (2009)